Compounds > hydrazine
Page last updated: 2024-08-21

hydrazine and Prostatic Neoplasms, Castration-Resistant

hydrazine has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aggarwal, R; Chang, E; Fong, L; Friedlander, TW; Kim, W; Lin, AM; Louttit, M; Ryan, CJ; Siegel, AP; Wei, XX; Zhang, L1
Alumkal, JJ; Bankhead, A; Bearss, J; Beer, TM; Berry, DL; Bisson, WH; Coleman, DJ; Gao, L; Haque, R; Heiser, LM; Joshi, SK; Kallakury, BVS; Kim, DH; King, CJ; McWeeney, SK; Sampson, DA; Schwartzman, J; Sehrawat, A; Sharma, S; Thomas, GV; Urrutia, J; Van Den Eeden, SK; Wang, Y; Weinmann, S1

Trials

1 trial(s) available for hydrazine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone- and/or Enzalutamide-Refractory Metastatic Castration-Resistant Prostate Cancer.
    The oncologist, 2018, Volume: 23, Issue:6

    Topics: Aged; Androstenes; Benzamides; Humans; Hydrazines; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Triazoles

2018

Other Studies

1 other study(ies) available for hydrazine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 05-01, Volume: 115, Issue:18

    Topics: Cell Survival; Gene Regulatory Networks; Histone Demethylases; Humans; Hydrazines; Male; Neoplasm Proteins; Prostatic Neoplasms, Castration-Resistant; Sulfonamides; Trans-Activators

2018